Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases
Details for Australian Patent Application No. 2005288522 (hide)
International Classifications
Event Publications
5 April 2007 PCT application entered the National Phase
PCT publication WO2006/035434 Priority application(s): WO2006/035434
23 August 2007 Change of Name(s) of Applicant(s), Section 104
Quark Biotech, Inc. The name of the applicant has been changed to Quark Pharmaceuticals, Inc.
28 June 2012 Application Accepted
Published as AU-B-2005288522
1 November 2012 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser